BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 10983954)

  • 21. The effect of topical Castellani solution on outer hair cell function of rats.
    Gültekin E; Yener M; Ozdemir I
    Laryngoscope; 2010 Apr; 120(4):808-12. PubMed ID: 20213791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
    Helling K; Schönfeld U; Clarke AH
    Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cochlear-vestibular ototoxicity by gentamicin. Report of a case and literature review].
    Pino Rivero V; Marcos García M; Keituqwa Yáñez T; González Palomino A; Trinidad Ruiz G; Pardo Romero G; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2004; 31(6):531-7. PubMed ID: 15663084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct round window application of gentamicin with varying delivery vehicles: a comparison of ototoxicity.
    Sheppard WM; Wanamaker HH; Pack A; Yamamoto S; Slepecky N
    Otolaryngol Head Neck Surg; 2004 Dec; 131(6):890-6. PubMed ID: 15577786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined administration of kanamycin and furosemide does not result in loss of vestibular function in Guinea pigs.
    Bremer HG; de Groot JC; Versnel H; Klis SF
    Audiol Neurootol; 2012; 17(1):25-38. PubMed ID: 21625081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM; Hehar SS; Bance ML; Rutka JA
    Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vestibular ototoxicity of gentamicin assessed by the recording of a short-latency vestibular-evoked response in cats.
    Elidan J; Lin J; Honrubia V
    Laryngoscope; 1987 Jul; 97(7 Pt 1):865-70. PubMed ID: 3496507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ototoxicity assessment of a gentamicin sulfate otic preparation in dogs.
    Strain GM; Merchant SR; Neer TM; Tedford BL
    Am J Vet Res; 1995 Apr; 56(4):532-8. PubMed ID: 7785834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study.
    Kim HH; Addison J; Suh E; Trune DR; Richter CP
    Laryngoscope; 2007 Jul; 117(7):1209-15. PubMed ID: 17603319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of noise on the vestibular system - Vestibular evoked potential studies in rats.
    Sohmer H; Elidan J; Plotnik M; Freeman S; Sockalingam R; Berkowitz Z; Mager M
    Noise Health; 1999; 2(5):41-52. PubMed ID: 12689484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct drug application to the round window: a comparative study of ototoxicity in rats.
    Murillo-Cuesta S; García-Alcántara F; Vacas E; Sistiaga JA; Camarero G; Varela-Nieto I; Rivera T
    Otolaryngol Head Neck Surg; 2009 Nov; 141(5):584-90. PubMed ID: 19861195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the ototoxicity of almond oil in a chinchilla animal model.
    Peleva E; Mourad S; Citra D; Daniel SJ
    Laryngoscope; 2011 Dec; 121(12):2661-4. PubMed ID: 22109768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does vestibular end-organ function recover after gentamicin-induced trauma in Guinea pigs?
    Bremer HG; Versnel H; Hendriksen FG; Topsakal V; Grolman W; Klis SF
    Audiol Neurootol; 2014; 19(2):135-50. PubMed ID: 24525357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ototoxicity of topical moxifloxacin in a chinchilla animal model.
    Daniel SJ; Duval M; Sahmkow S; Akache F
    Laryngoscope; 2007 Dec; 117(12):2201-5. PubMed ID: 18322423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cochlear and Vestibular Effects of Combined Intratympanic Gentamicin and Dexamethasone.
    Güneri EA; Olgun Y; Aslıer M; Nuti D; Kırkım G; Mungan S; Kolatan E; Aktaş S; Trabalzini F; Ellidokuz H; Yılmaz O; Mandala M
    J Int Adv Otol; 2017 Apr; 13(1):47-52. PubMed ID: 28084995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of evoked potentials to objectively differentiate between selective vulnerability of cochlear and vestibular end organ function.
    Freeman S; Priner R; Mager M; Sichel JY; Perez R; Elidan J; Sohmer H
    J Basic Clin Physiol Pharmacol; 2000; 11(3):193-200. PubMed ID: 11041383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed electrical stimulation and BDNF application following induced deafness in rats.
    Song BN; Li YX; Han DM
    Acta Otolaryngol; 2009 Feb; 129(2):142-54. PubMed ID: 18607918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lateralization during the Weber test: animal experiments.
    Sichel JY; Freeman S; Sohmer H
    Laryngoscope; 2002 Mar; 112(3):542-6. PubMed ID: 12148868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ototoxicity of ototopical antibiotic drops in humans.
    Matz G; Rybak L; Roland PS; Hannley M; Friedman R; Manolidis S; Stewart MG; Weber P; Owens F
    Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S79-82. PubMed ID: 15054365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cochlear implantation in children with anomalous cochleovestibular anatomy.
    Papsin BC
    Laryngoscope; 2005 Jan; 115(1 Pt 2 Suppl 106):1-26. PubMed ID: 15626926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.